Sight Sciences, Inc. (SGHT)

$6.95

+0.07 (+1.02%)
Rating:
Recommendation:
-
Symbol SGHT
Price $6.95
Beta 0.000
Volume Avg. 0.21M
Market Cap 332.392M
Shares () -
52 Week Range 5.95-27.7
1y Target Est -
DCF Unlevered SGHT DCF ->
DCF Levered SGHT LDCF ->
ROE -38.27% Strong Sell
ROA -35.04% Strong Sell
Operating Margin -
Debt / Equity 25.55% Neutral
P/E -
P/B 1.73 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest SGHT news


Mr. Paul Badawi
Healthcare
Medical Devices
NASDAQ Global Select

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.